Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands
Open Access
- 1 September 2017
- journal article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 47, 117-125
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cost-effectiveness of screening for hepatitis C virus: a systematic review of economic evaluationsBMJ Open, 2016
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 InfectionNew England Journal of Medicine, 2014
- A systematic review of hepatitis C virus epidemiology in Europe, Canada and IsraelLiver International, 2011
- Introduction: A smouldering public-health crisisNature, 2011
- A support programme for primary care leads to substantial improvements in the effectiveness of a public hepatitis C campaignFamily Practice, 2010
- Population‐based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004Journal of Medical Virology, 2007
- The cost-effectiveness of testing for hepatitis C in former injecting drug usersHealth Technology Assessment, 2006
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Management of chronic hepatitis C: clinical audit of biopsy based management algorithmBMJ, 1997
- Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus InfectionNew England Journal of Medicine, 1996